Jessie Peh

Targeting Toxic RNAs that Cause Myotonic Dystrophy Type 1 (DM1) with a Bisamidinium Inhibitor

Chun‐Ho Wong, Lien Nguyen, Jessie Peh et al. · Journal of the American Chemical Society · 2014 · 100 citations · Full text

Detection of Protein–Small Molecule Binding Using a Self-Referencing External Cavity Laser Biosensor

Meng Zhang, Jessie Peh, Paul J. Hergenrother et al. · Journal of the American Chemical Society · 2014 · 29 citations · Full text

Single-cell analysis of early antiviral gene expression reveals a determinant of stochastic <i>IFNB1</i> expression

Sultan Doğanay, Maurice Youzong Lee, Alina Baum et al. · Integrative Biology · 2017 · 25 citations · Full text

The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas

Jessie Peh, Timothy M. Fan, Kathryn L. Wycislo et al. · Molecular Cancer Therapeutics · 2016 · 23 citations · Full text

Braf Mutation, Mutant Braf Melanomas, Medicine +12

Overcoming Resistance to Targeted Anticancer Therapies through Small-Molecule-Mediated MEK Degradation

Jessie Peh, Matthew W. Boudreau, Hannah M. Smith et al. · Cell chemical biology · 2018 · 23 citations · Full text

Tumor Biology, Drug Targeting, Receptor Tyrosine Kinase +10